KOE:068760
Celltrion Pharm, Inc. · KOE · Healthcare · KRW · FY for 2025
Figures on this page computed 2026-11-08 13:28 UTC
Last close
n/aKRW
Market data
44.4xP/E
Price / Earnings per Share (diluted)
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- KRW
- computed
- Computed from the filing for 2025
n/aROIC
We do not hold this figure for this company, so there is nothing to place.
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- KRW
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
7.2%Net margin
Net Income / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- KRW
- Computed from the filing for 2025
- Computed from the filing for 2025
12.8%FCF margin
Free Cash Flow / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- KRW
- Computed from the filing for 2025
- Computed from the filing for 2025
n/aDebt/equity
We do not hold this figure for this company, so there is nothing to place.
Total Debt / Shareholders' Equity
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- KRW
- Computed from the filing for 2025
- Computed from the filing for 2025
n/aDividend yield
We do not hold this figure for this company, so there is nothing to place.
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- KRW
- computed
Price is the furthest below its sector's middle: 0.25 against 0.37 on the market's range.
- Growth18.1%72 of 100, above its sector
- Returns on capital8.9%70 of 100, above its sector
- Margins30.0%62 of 100, above its sector
- Price44.4x25 of 100, below its sector
- Safety1.6662 of 100, above its sector
- What it pays outn/anot placed
- What it pays out: n/aWe do not hold this figure for this company, so there is nothing to place.
Six questions
lens 5 of 9Six questions
5 yes of 6 answered- 1Does it earn money?yes
net margin, read above 0.
- 2Can it pay what it owes?yes
interest coverage, read above 3.
- 3Is it bigger than five years ago?yes
rev growth 5y, read above 0.
- 4Does the profit turn into cash?yes
fcf margin, read above 0.
- 5Is it issuing shares?yes
share count change yoy, read below 1.
- 6Is it priced under twenty times earnings?no
pe ratio, read below 20.
5 of 6 questions answered yes; 0 could not be answered.
5 of 6 questions answered yes; 0 could not be answered.
Every figure in this lens
Except where said otherwise: Computed from the filing for 2025
Does it earn money?7.2%
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- KRW
Can it pay what it owes?8.4x
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- KRW
Is it bigger than five years ago?18.1%
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- KRW
Does the profit turn into cash?12.8%
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- KRW
Is it issuing shares?-0.03%
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- KRW
Is it priced under twenty times earnings?44.4x
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- KRW